Last updated: February 15, 2026
Overview:
ND Visit: 24385-0054 is a marketed pharmaceutical product, identified by the National Drug Code (NDC). Its specific therapeutic class, labeling, and indications are crucial for accurate market and price analysis.
Product Profile:
- Drug Name: Not specified; NDC code indicates a contained product in the U.S. market.
- Formulation and Strength: Typically detailed in the FDA database.
- Indication: To assess market size, the primary indication, patient population, and competitive landscape are examined.
Market Landscape:
1. Therapeutic Area & Competition:
The product's therapeutic class impacts market penetration and pricing strategies. If it is a specialty drug (e.g., oncology, rare diseases), it typically commands higher prices and has smaller patient pools. Chronic disease medications (e.g., diabetes, hypertension) tend to have larger markets.
- Key competitors: Identification via U.S. FDA Orange Book and sales databases is necessary. Competitors define price benchmarks.
2. Market Size & Patient Demographics:
National surveys and claims data indicate the approximate number of patients eligible for this treatment. Variations occur due to the drug's approved indications, regulatory status, and geographic coverage.
- Estimate Total Addressable Market (TAM): Based on disease prevalence and insurance coverage.
- Potential Patient Pool: A subset of TAM, representing diagnosed and treatable cases.
3. Pricing & Reimbursement Landscape:
Pricing depends heavily on whether the drug is branded or generic, its formulary placement, and reimbursement policies. Specific considerations:
- Branded drugs: Typically priced between $10,000 and $50,000 annually per patient, depending on the therapeutic class.
- Generic versions: Prices often under $5,000 annually.
- Insurance & PBM Negotiations: Reimbursement rates vary, influencing net revenue.
Historical Pricing Data & Trends:
| Year |
Average Wholesale Price (AWP) |
Estimated Launch Price |
Price Trends |
| 2018 |
$X |
$Y |
Moderate price increase, stable in niche segments |
| 2020 |
$X+10% |
$Y+5% |
Slight increase driven by new indications |
| 2022 |
$X+15% |
$Y+10% |
Price stabilization with entry of generics |
4. Regulatory & Policy Drivers:
- FDA Approval Status: Impacts market access.
- Patent & Exclusivity Periods: Determine period of market exclusivity and pricing power.
- Medicare & Medicaid: Price negotiations influence net revenue.
Price Projections:
-
Short-term (next 1-2 years):
If a proprietary product with recent FDA approval and no generics, expect prices to remain stable or slightly increase driven by inflation and supply chain costs.
-
Mid-term (3-5 years):
Entry of generics or biosimilars could reduce prices by 30–50%. If patent protection is approaching expiry, prices could decline accordingly.
-
Long-term (>5 years):
Market consolidation, new competitors, or changes in treatment guidelines could further impact prices.
Factors influencing projections:
- Patent status and exclusivity rights.
- Approval of biosimilars or generics.
- Changes in healthcare policies and drug rebate structures.
- Off-label use and expansion of indications.
Key Takeaways:
- Market size depends on the therapeutic indication and patient population.
- Pricing strategies are shaped by competition, regulatory status, and reimbursement dynamics.
- The price trajectory reflects patent protections, generics entry, and healthcare policy shifts.
- The existing notes suggest a branded drug likely priced between $10,000–$50,000 annually; generics could reduce this by up to 50%.
FAQs
1. What is the typical price range for drugs similar to NDC 24385-0054?
Branded therapies in niche markets can cost $20,000–$50,000 annually per patient, while generics range from less than $5,000 to $10,000.
2. How do patent expirations influence drug pricing?
Patent expiration enables generic competition, which often reduces prices by 30–50% or more.
3. What factors determine reimbursement levels?
Reimbursement depends on formulary placement, negotiated rebates, and payer policies.
4. Which regulatory elements impact market entry?
FDA approval status, patent protections, and any orphan drug designations influence time to market and pricing.
5. How will healthcare policy changes affect future prices?
Policy shifts toward cost containment and drug pricing transparency may result in lower artificially-inflated prices or increased pressure on rebates and discounts.
Sources:
- FDA Orange Book, 2023.
- IQVIA Institute reports, 2023.
- CMS drug pricing policies, 2023.
- Keytruda pricing and market data reports, 2022.
- Generic drug price index, 2023.
